Almond for Physical Performance

May 3, 2022 updated by: Mark Kern, San Diego State University

Roles of Almonds in Physical Performance

Investigators specific aims are to compare the effects of consuming daily snacks of raw, shelled, unsalted almonds (2.0 ounces) versus an isocaloric amount of another commonly consumed snack food (pretzels) on energy (vigor) perception and physical activity, exercise performance (VO2max and measures of strength), strength and power performance as well as muscle soreness recovery after strenuous eccentrically-biased exercise.

Study Overview

Status

Completed

Conditions

Detailed Description

To accomplish these aims, investigators will examine whether regular consumption of almonds versus a common snack food over a period of 8 weeks impacts longer term metabolic, physiological and behavioral responses related to energy sensations and exercise capacity/performance.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92182-7251
        • San Diego State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 30-50 years old
  • BMI of 23-30

Exclusion Criteria:

  • smoking,
  • medications known to impact inflammation,
  • musculoskeletal limitations and
  • use of supplements within 1 month of participation that are known to impact antioxidant
  • use of supplements within 1 month of participation that are known to impact inflammatory status

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Almond
Participants will consume 2.0 oz of raw, shelled, unsalted almonds.
2.0 oz of raw, shelled, unsalted almonds
Active Comparator: Control group
an isocaloric (2.0 oz raw almonds) amount of unsalted pretzels daily.
an isocaloric amount of unsalted pretzels

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in energy (vigor) perception
Time Frame: At baseline , at 8 weeks
Energy (vigor) perception will be assessed using POMS questionnaire
At baseline , at 8 weeks
Changes from baseline in exercise performance
Time Frame: At baseline , at 8 weeks
VO2max will be assessed for measuring exercise performance
At baseline , at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in strength and power performance
Time Frame: At baseline, at 8 weeks
strength and power performance by be measure by biodex
At baseline, at 8 weeks
Changes from baseline in muscle soreness
Time Frame: At baseline, at 8 weeks
muscle soreness will be measured by DOMES questionnaire
At baseline, at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2020

Primary Completion (Actual)

May 3, 2022

Study Completion (Actual)

May 3, 2022

Study Registration Dates

First Submitted

March 3, 2021

First Submitted That Met QC Criteria

March 5, 2021

First Posted (Actual)

March 9, 2021

Study Record Updates

Last Update Posted (Actual)

May 5, 2022

Last Update Submitted That Met QC Criteria

May 3, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Soreness

Clinical Trials on Almond

3
Subscribe